EULAV Asset Management’s Ingevity NGVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-15,100
Closed -$1.32M 269
2019
Q4
$1.32M Sell
15,100
-1,000
-6% -$87.4K 0.05% 237
2019
Q3
$1.37M Sell
16,100
-2,600
-14% -$232K 0.05% 242
2019
Q2
$1.97M Buy
18,700
+5,300
+40% +$533K 0.07% 214
2019
Q1
$1.47M Buy
+13,400
New +$1.35M 0.06% 228

Other funds holding NGVT

EULAV Asset Management's NGVT Position: Q1 2020 in Review

EULAV Asset Management sold out of Ingevity (NGVT) in Q1 2020, closing a stake of 15,100 shares — an estimated $1.32M sold.

EULAV Asset Management first reported a position in NGVT in Q1 2019 and held it in 4 quarters. The position peaked at $1.97M in Q2 2019. 272 funds tracked by Wall St. Rank hold NGVT as of Q1 2020.

  • EULAV Asset Management reported no remaining Ingevity position as of Q1 2020 after selling out during the quarter.
  • EULAV Asset Management sold 15,100 Ingevity shares in Q1 2020, an estimated $1.32M.
  • EULAV Asset Management first reported a position in Ingevity in Q1 2019 and held it in 4 quarters.
  • EULAV Asset Management's Ingevity position peaked at $1.97M in Q2 2019.
  • 272 funds tracked by Wall St. Rank held Ingevity as of Q1 2020.

Based on EULAV Asset Management's 13F filing for Q1 2020, filed 27 Apr 2020.